Alphavac
Device Vit
PDI H787253010
General payments
$1,105,872
Research payments
$926,988
Through program year 2025, $1,105,872 in general payments and $926,988 in research payments were reported against Alphavac (Vit).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $544,256 | 2,792 |
| 2025 | Research | $4,948 | 4 |
| 2024 | General | $282,508 | 1,861 |
| 2024 | Research | $385,319 | 57 |
| 2023 | General | $179,133 | 1,541 |
| 2023 | Research | $536,721 | 83 |
| 2022 | General | $99,976 | 1,872 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 61 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
8,066 general · 144 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.